BIOT

Instinct Bio Technical Company Holdings Inc

0.1901

Nov 13 • 3:59 PM ET +0.0001 (0.05%)

0.2090

Aftermarket • 6:11 PM ET +0.0189 (9.94%)

Consumer Defensive Household & Personal Products Japan Nano NASD

Peers: BYAH YSG NUS SKIN EL SLSN UG ATTT DSY JWEL

Scroll to Statements

Index	-
Market Cap	5.47M
Enterprise Value	5.61M
Income	-0.78M
Sales	0.00M
Book/sh	0.09
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	2
IPO	Apr 04, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	2.01
P/C	182.43
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.36
Current Ratio	1.61
Debt/Eq	0.08
LT Debt/Eq	0.04
Option/Short	No / Yes

EPS (ttm)	-0.18
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -416.29%
Sales past 3/5Y	- -
EPS Y/Y TTM	-17.05%
Sales Y/Y TTM	-
EPS Q/Q	95.72%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	57.00%
Insider Trans	0.00%
Inst Own	6.13%
Inst Trans	-
ROA	-99.87%
ROE	-
ROIC	-36.10%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-1.61%
SMA50	-37.48%
SMA200	-97.07%
Trades

Shs Outstand	28.79M
Shs Float	12.38M
Short Float	0.22%
Short Ratio	0.07
Short Interest	0.03M
52W High	50.00 -99.62%
52W Low	0.17 15.21%
Volatility	12.71% 13.59%
ATR (14)	0.04
RSI (14)	36.34
Beta	-
Rel Volume	0.53
Avg Volume	405.20K
Volume	213,482

Perf Week	8.66%
Perf Month	-31.02%
Perf Quarter	-49.89%
Perf Half Y	-97.89%
Perf YTD	-98.45%
Perf Year	-98.45%
Perf 3Y	-98.45%
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.19
Price	0.19
Change %	0.05%

Oct-16-26 08:30AM	Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026 (NewMediaWire) -17.16%
Sep-30-26 08:00AM	BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China (NewMediaWire)
Sep-28-26 02:06PM	AI agent startup Instinct hits $10 billion valuation following $1 billion round (Investing.com) -5.48%
Sep-15-26 08:00AM	Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares (NewMediaWire)
Sep-04-26 07:00AM	INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives (GlobeNewswire)
07:00AM	Loading…
Aug-10-26 07:00AM	Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia (GlobeNewswire)
Jul-30-26 09:18AM	Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives (NewMediaWire) -10.91%
Jul-29-26 10:28AM	BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand "GENRÊVER CLINIC" - Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets (GlobeNewswire) -57.89%

Instinct Bio Technical Co. Holdings, Inc. is an integrated regenerative medicine and longevity company focused on research, manufacturing, and commercialization of regenerative health technologies. It develops stem cell-derived products, wellness solutions, and advanced skincare products. The company was founded in 2017 is headquartered in Tokyo Japan.

FounderMr. Tomoki Nagano

Chief Financial OfficerMr. Masashi Ohmatsu

Senior Executive Managing DirectorMr. Yuji Naito

Chief Marketing Officer & Representative DirectorMr. Fumihiro Nagano

Chief Technical OfficerMr. Futa Sakakibara Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

BIOT

Instinct Bio Technical Company Holdings Inc

Upgrade your Finviz experience

All the Features.
Half the Price.